The Enterprise Value as of December 2025 (TTM) for CG Oncology, Inc. Common stock (CGON) is 3.32B

According to CG Oncology, Inc. Common stock’s latest financial reports and current stock price. The company's current Enterprise Value is 3.32B. This represents a change of 56.96% compared to the average of 2.11B of the last 4 quarters.

CG Oncology, Inc. Common stock (CGON) Historical Enterprise Value (quarterly & annually)

How has CGON Enterprise Value performed in the past?

The mean historical Enterprise Value of CG Oncology, Inc. Common stock over the last ten years is 2.21B. The current 3.32B Enterprise Value has changed 14.89% with respect to the historical average. Over the past ten years (40 quarters), CGON's Enterprise Value was at its highest in in the September 2025 quarter at 3.05B. The Enterprise Value was at its lowest in in the June 2023 quarter at 0.

CG Oncology, Inc. Common stock (CGON) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CG Oncology, Inc. Common stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

CG Oncology, Inc. Common stock (CGON) Average Enterprise Value

How has CGON Enterprise Value performed in the past?

The current Enterprise Value of CG Oncology, Inc. Common stock (CGON) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

CG Oncology, Inc. Common stock (CGON) Enterprise Value vs. Peers

How is CGON’s Enterprise Value compared to its peers?

CG Oncology, Inc. Common stock’s Enterprise Value is less than Celcuity Inc. (5.14B), less than ASCENTAGE PHARMA GROUP INTERNATIONAL (20.23B), less than Centessa Pharmaceuticals plc (4.05B), less than Apogee Therapeutics, Inc. (4.04B), less than Xenon Pharmaceuticals Inc. (3.32B), less than Travere Therapeutics, Inc. (3.38B), less than Ultragenyx Pharmaceutical Inc. (3.33B), greater than Legend Biotech Corporation (2.68B), less than Disc Medicine, Inc. (3.43B), less than Tarsus Pharmaceuticals, Inc. (3.36B),

Build a custom stock screener for CG Oncology, Inc. Common stock (CGON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CG Oncology, Inc. Common stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CG Oncology, Inc. Common stock (CGON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CG Oncology, Inc. Common stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.